Open Access Email this article to a friend

Inclusion of MUC1 (Ma695) in a panel of immunohistochemical markers is useful for distinguishing between endocervical and endometrial mucinous adenocarcinoma*

Thaer Khoury*, Dongfeng Tan, Jianmin Wang, Marilyn Intengan, Jun Yang, Sadir Alrawi, Peisha Yan and James C Byrd

BMC Clinical Pathology 2006, 6:1  doi:10.1186/1472-6890-6-1

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.
How can I ensure that I receive BMC Clinical Pathology's emails?